Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1510-25-4 | MDL No. : | MFCD09025658 |
Formula : | C13H9NS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YASUKDIZQBZXRW-UHFFFAOYSA-N |
M.W : | 211.28 | Pubchem ID : | 23424511 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 66.56 |
TPSA : | 44.45 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.05 cm/s |
Log Po/w (iLOGP) : | 2.74 |
Log Po/w (XLOGP3) : | 4.99 |
Log Po/w (WLOGP) : | 4.09 |
Log Po/w (MLOGP) : | 4.77 |
Log Po/w (SILICOS-IT) : | 5.16 |
Consensus Log Po/w : | 4.35 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.75 |
Solubility : | 0.00373 mg/ml ; 0.0000176 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.66 |
Solubility : | 0.000459 mg/ml ; 0.00000217 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.12 |
Solubility : | 0.00161 mg/ml ; 0.00000764 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.28 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With dmap In dichloromethane at 20℃; for 1 h; Inert atmosphere | To a stirred solution of biphenyl-3-ylamine (338 mg, 2 mmol) in DCM (5 mL), thiocarbonyldiimidazole (TCDI) (535 mg, 3 mmol) and DMAP (48.8 mg, 0.04 mmol) were added and the reaction mixture stirred at r.t under N2 for 1 h (until TLC showed no starting material remaining). The reaction mixture was then purified by a silica plug (DCM). The solvent was then removed in vacuo to leave a colourless oil (407 mg, 96percent). Rf: 0.86 (1:1 DCM/hex). 1H NMR (CDCl3): δ 7.16 (ddd, 1H, J 8, 2, 1 Hz, H6'), 7.34-7.48 (m, 6H, H4'', H5', H4', H3'', H5'', H2'), 7.52 (m, 2H, H2'', H6''). 13C NMR (CDCl3): δ 124.4 (CH), 124.5 (CH), 126.2 (CH), 127.2 (CH), 128.2 (CH), 129.1 (CH), 130.0 (CH), 131.8 (C), 135.7 (NCS), 139.5 (C), 143.0 (C). |
[ 2113-55-5 ]
[1,1'-Biphenyl]-3-amine hydrochloride
Similarity: 0.67
[ 118727-34-7 ]
1,3,5-Tris(4-aminophenyl)benzene
Similarity: 0.66
[ 206559-36-6 ]
3-Benzyloxyphenylisothiocyanate
Similarity: 0.63